跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
Approved
化学药品
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Nov 12, 2024
Approval ID
8etnVucXcDl
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
8etnVucXcDl
Approval Number
国药准字HJ20190061
Generic Name
索磷维伏片
Generic Name En
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
Trade Name
沃士韦
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含400mg索磷布韦、100mg维帕他韦和100mg伏西瑞韦
Reg Date
2024-11-12
Expired Date
2029-11-11
Company Name
GILEAD SCIENCES IRELAND UC
Production Company Name
GILEAD SCIENCES IRELAND UC
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/gilead-sciences-ireland-uc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 12, 2024
Approval ID
8etnVucXcDl
Type
化学药品
Back to NMPA Approvals
沃士韦 - NMPA Drug Approval Details
